Oramed Pharmaceuticals
ORMP
#9009
Rank
ยฃ0.15 B
Marketcap
ยฃ3.77
Share price
6.56%
Change (1 day)
133.48%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): ยฃ58.3 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of ยฃ57.1 Million, an increase over its 2024 earnings that were of -ยฃ11.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ58.3 M2.09%
2025 ยฃ57.1 M-616.9%
2024 -ยฃ11.05 Million-311.47%
2023 ยฃ5.22 M-119.45%
2022 -ยฃ26.86 Million39.17%
2021 -ยฃ19.3 Million73.93%
2020 -ยฃ11.1 Million18.53%
2019 -ยฃ9.37 Million-16.62%
2018 -ยฃ11.23 Million38.32%
2017 -ยฃ8.12 Million12.51%
2016 -ยฃ7.22 Million25.01%
2015 -ยฃ5.78 Million18.18%
2014 -ยฃ4.89 Million39.72%
2013 -ยฃ3.5 Million46.4%
2012 -ยฃ2.39 Million128.32%
2011 -ยฃ1.05 Million-51.47%
2010 -ยฃ2.16 Million35.21%
2009 -ยฃ1.6 Million
2007 -ยฃ2.51 Million607.04%
2006 -ยฃ0.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
ยฃ18.33 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ5.61 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.4 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ19.13 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ25.57 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel